Article
Autophagy is required to maintain muscle mass.
Dulbecco Telethon Institute, 35129 Padova, Italy.
Cell metabolism (impact factor:
17.35).
12/2009;
10(6):507-15.
DOI:10.1016/j.cmet.2009.10.008
pp.507-15
Source: PubMed
-
Citations (0)
- Cited In (17)
-
Article: Intracellular signaling in ER stress-induced autophagy in skeletal muscle cells.
[show abstract] [hide abstract]
ABSTRACT: Skeletal muscle remodeling in response to muscle disuse and unloading is known to be associated with so-called ER stress, which, in turn, activates autophagy and contributes to muscle atrophy. Different molecules are involved in ER stress-induced autophagy, among which PKCθ has recently been described. In this study, we dissected both in vitro and in vivo ER stress-induced autophagy pathways in muscle. Using C(2)C(12) muscle cells in culture, we demonstrated that PKC activation induced autophagy in the absence of ER stress. We further demonstrated that PKCθ was strongly activated in cultured myoblasts and myotubes during ER stress induced by different stimuli, such as TG or TN treatment, and that it localized into Lc3-positive autophagic dots upon TG treatment. Neither Akt dephosphorylation nor Foxo or GSK3β activation was observed in these conditions. Moreover, PKCθ inhibition in myoblasts and myotubes prevented ER stress-induced Lc3 activation and autophagic dot formation, but not ER stress. In vivo, lack of PKCθ prevented both food deprivation- and immobilization-induced autophagy and muscle atrophy, irrespective of Akt pathway inhibition. Taken together, these results demonstrate that PKCθ functions as an ER stress sensor in skeletal muscle, required for ER-stress-dependent autophagy activation, and can be proposed as a novel molecular target to maintain muscle homeostasis in response to external stimuli, such as disuse and unloading, still allowing intracellular clearance.-Madaro, L., Marrocco, V., Carnio, S., Sandri, M., Bouché, M. Intracellular signaling in ER stress-induced autophagy in skeletal muscle cells.The FASEB Journal 02/2013; · 5.71 Impact Factor -
Article: Molecular and cellular mechanisms of skeletal muscle atrophy: an update.
[show abstract] [hide abstract]
ABSTRACT: Skeletal muscle atrophy is defined as a decrease in muscle mass and it occurs when protein degradation exceeds protein synthesis. Potential triggers of muscle wasting are long-term immobilization, malnutrition, severe burns, aging as well as various serious and often chronic diseases, such as chronic heart failure, obstructive lung disease, renal failure, AIDS, sepsis, immune disorders, cancer, and dystrophies. Interestingly, a cooperation between several pathophysiological factors, including inappropriately adapted anabolic (e.g., growth hormone, insulin-like growth factor 1) and catabolic proteins (e.g., tumor necrosis factor alpha, myostatin), may tip the balance towards muscle-specific protein degradation through activation of the proteasomal and autophagic systems or the apoptotic pathway. Based on the current literature, we present an overview of the molecular and cellular mechanisms that contribute to muscle wasting. We also focus on the multifacetted therapeutic approach that is currently employed to prevent the development of muscle wasting and to counteract its progression. This approach includes adequate nutritional support, implementation of exercise training, and possible pharmacological compounds.Journal of cachexia, sarcopenia and muscle. 06/2012; 3(3):163-79. -
Article: Autophagy: an emerging immunological paradigm.
[show abstract] [hide abstract]
ABSTRACT: Autophagy is a fundamental eukaryotic process with multiple cytoplasmic homeostatic roles, recently expanded to include unique stand-alone immunological functions and interactions with nearly all parts of the immune system. In this article, we review this growing repertoire of autophagy roles in innate and adaptive immunity and inflammation. Its unique functions include cell-autonomous elimination of intracellular microbes facilitated by specific receptors. Other intersections of autophagy with immune processes encompass effects on inflammasome activation and secretion of its substrates, including IL-1β, effector and regulatory interactions with TLRs and Nod-like receptors, Ag presentation, naive T cell repertoire selection, and mature T cell development and homeostasis. Genome-wide association studies in human populations strongly implicate autophagy in chronic inflammatory disease and autoimmune disorders. Collectively, the unique features of autophagy as an immunological process and its contributions to other arms of the immune system represent a new immunological paradigm.The Journal of Immunology 07/2012; 189(1):15-20. · 5.79 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
aberrant concentric membranous structures
abnormal mitochondria
age-dependent decrease
Atg7 null muscles
autophagy flux
Autophagy inhibition exacerbated muscle loss
autophagy-lysosome pathways
crucial autophagy gene
denervation
excessive activation induces severe muscle loss
FoxO regulation
inhibition/alteration
muscle disorders
muscle mass
muscle-specific deletion
myofiber degeneration
profound muscle atrophy
sarcoplasmic reticulum distension
skeletal muscle
two major routes